🔵 RESEARCH
Trial tests if image acquisition breaks cervical ultrasound AI
A prospective trial will evaluate whether varying cervical ultrasound acquisition settings degrade an existing AI model's performance in predicting spontaneous preterm birth.
Acquisition variability is the unsolved bottleneck blocking commercial scale-up of obstetric ultrasound AI. Findings could entrench OEMs with installed bases — GE, Philips, Samsung Medison — who can dictate favourable protocols, while hardware-agnostic AI vendors face a tougher credentialing path.
⚪ INDUSTRY
Portable ultrasound market projected to reach $4.1B by 2032
Healthcare Asia Magazine cited forecasts placing the portable ultrasound scanners market at $4.1 billion by 2032.
The forecast reinforces POCUS as a high-conviction growth segment, intensifying pressure on GE HealthCare and Philips while drawing capital toward chip-based challengers like Butterfly and Exo. Expect consolidation as incumbents look to acquire AI-native POCUS startups before pricing compresses.
Google News: POCUS point-of-care ultrasound · Wed, 20 Ma
Read more →
⚪ INDUSTRY
Japan ultrasound device forecast extends growth runway to 2034
A market report outlined trends and forecasts for Japan's ultrasound devices market through 2034, framing it as a sustained Asia-Pacific growth vector.
Japan's ageing demographic anchors a long demand curve favouring Fujifilm, Canon Medical and GE HealthCare, all of whom hold entrenched distribution. POCUS challengers like Butterfly face high regulatory and channel costs — watch for sogo shosha partnerships as the likely entry route.
Google News: POCUS point-of-care ultrasound · Tue, 19 Ma
Read more →
🩺 EDITOR’S TAKE — FOR CLINICIANS
Acquisition variability is the unglamorous bottleneck behind AI's clinical credibility. Before adopting cervical ultrasound AI or POCUS tools, ask vendors for performance data stratified by operator experience and scanner settings — not just headline AUCs.
📊 EDITOR’S TAKE — FOR INVESTORS
Two market forecasts and a standardisation trial all point the same direction: POCUS TAM is real, but moats will be built on acquisition protocols and distribution, not algorithms alone. Favour OEMs with installed bases over hardware-agnostic AI pure-plays.
🏭 EDITOR’S TAKE — FOR INDUSTRY
Whoever shapes acquisition standards shapes the market. Incumbents like GE HealthCare, Philips, Canon and Fujifilm can co-author protocols that lock in their hardware; challengers like Butterfly need channel partnerships — particularly in Japan — to convert forecast TAM into revenue.